名称 | 銘柄コード | 市場 | 種別 |
---|---|---|---|
Chromocell Therapeutics Corporation | CHRO | AMEX | 普通株式 |
始値 | 安値 | 高値 | 終値 | 前日終値 |
---|---|---|---|---|
2.00 | 1.73 | 2.00 | 1.82 | 1.75 |
最新ニュース
日付 | 時間 | ソース | タイトル |
---|---|---|---|
2024/5/16 | 05:15 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
2024/5/16 | 05:06 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
2024/5/13 | 22:00 | GLOBE | Chromocell To Present at Alliance Global Partner’s.. |
2024/4/09 | 21:30 | GLOBE | Chromocell Issues Letter to Stockholders from Chief.. |
2024/3/21 | 21:30 | GLOBE | Chromocell Announces Formal Launch of Eye Pain Treatment.. |
2024/3/18 | 23:00 | GLOBE | Chromocell Names Frank Knuettel as Chief Executive Officer,.. |
2024/3/11 | 22:00 | GLOBE | Chromocell to Present at Sidoti Virtual Investor Conference.. |
2024/2/27 | 22:00 | GLOBE | Benuvia Operations, LLC and Chromocell Therapeutics Corp... |
2024/2/22 | 06:47 | GLOBE | Chromocell Therapeutics Announces Closing of Initial Public.. |
2024/2/16 | 22:00 | GLOBE | Chromocell Therapeutics Announces Pricing of Upsized $6.6.. |